FIELD: medicine, gastroenterology, endocrinology. SUBSTANCE: method involves administration to patients of preparation quamatel (famotidine) in the dose 80 mg orally, 2 time per 24 h for 3 weeks, not less. Method provides reliable decrease of blood glucose concentration and increase of the level of plasma blood immunoreactive insulin in combination with effective ulcer scarring. Invention can be used in treatment of patients with diabetes mellitus type II with exacerbation of chronic gastroduodenal ulcers. EFFECT: enhanced effectiveness of treatment. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF PATIENT WITH ULCEROUS DISEASES COMBINED WITH DIABETES MELLITUS | 2004 |
|
RU2278676C1 |
METHOD FOR SELECTING DUODENAL PEPTIC ULCER TREATMENT TYPE | 2003 |
|
RU2252709C1 |
METHOD FOR TREATING PATIENTS FOR GASTRIC AND DUODENAL PEPTIC ULCER AGGRAVATED WITH CARDIAC ISCHEMIA DISEASE | 2005 |
|
RU2288728C2 |
METHOD OF TREATMENT OF PATIENTS WITH DUODENUM ULCER DISEASE OF MODERATE SEVERITY | 2000 |
|
RU2173991C1 |
METHOD OF TREATING ULCEROUS DISEASE OF DUODENUM IN CHILDREN, ASSOCIATED WITH FUNGUS OF GENUS Candida | 2009 |
|
RU2416405C1 |
ANTI-ULCER MEDICAMENT AND METHOD FOR TREATING GASTRIC AND DUODENAL PEPTIC ULCER DISEASE | 2000 |
|
RU2183458C2 |
METHOD FOR TREATING THE PATIENTS WITH ULCEROUS GASTRIC DISEASE AT DECREASED GASTRIC SECRETION | 2000 |
|
RU2188010C2 |
METHOD OF GASTRO-DUODENAL ZONE ULCER TREATMENT | 2008 |
|
RU2365378C1 |
METHOD OF TREATMENT OF PATIENT WITH DIABETIC FOOT SYNDROME | 1998 |
|
RU2144831C1 |
THERAPY METHOD FOR SLUGGISH ULCERS AND EROSIONS IN GASTRODUODENAL SYSTEM | 2003 |
|
RU2261091C2 |
Authors
Dates
2002-11-10—Published
2001-05-25—Filed